pharmaceutical investing Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304
Allied Critical Metals Appoints General James A. "Spider" Marks as a Director of Allied Critical Metals USA, Its U.S. Subsidiary Focused on Tungsten Import and Sales
